跳至主要内容
临床试验/JPRN-UMIN000012243
JPRN-UMIN000012243已完成未知

Safety and efficacy of extended pyrazinamide (PZA) administration for prolonged smear positive pulmonary tuberculosis - Safety and efficacy of extended pyrazinamide (PZA) administration for prolonged smear positive pulmonary tuberculosis

ational Center for Global Health and Medicine0 个研究点目标入组 40 人开始时间: 2013年11月8日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)HIV positive 2)Systemic corticosteroids or other imunosuppressants administration 3)Pregnancy or breast feeding 4)Resistance of INH and/or RFP 5)Hyperuricemia or past history of gout 6)Any laboratory abnormal finding as follows; T-bil >= 3.0 mg/dL, WBC < 2,000 /mm3, Hgb < 7.0 g/dL, or Plt < 50,000 /mm3 7)Others judjed to be unsuitable as subjects by the physicians in charge

研究者

发起方
ational Center for Global Health and Medicine

相似试验

Safety and efficacy of extended pyrazinamide (PZA)... | 临床试验